BioSpace News Archive

Employer Resources

Webinar: Building a Culture of Inclusion

How can life science workplaces improve not only diversity but create enduring inclusivity that not only empowers employees but fosters a culture of success and mutual trust?

October 6, 2023
·
5 min read
·
Chantal Dresner
Drug Development

Moberg Pharma has completed enrollment to the Phase 3 study for MOB-015 in North America

Moberg Pharma AB has completed the recruitment of 384 patients with onychomycosis for the ongoing MOB-015 phase 3 study in North America.

October 6, 2023
·
3 min read
Bio NC

Verona Pharma to Host Investor Update on Commercialization Preparation for Ensifentrine on October 18, 2023

Verona Pharma plc, announces it will hold an Investor Update in New York City for investors and analysts on Wednesday, October 18, 2023, from 8:00 - 10:00 AM ET.

October 6, 2023
·
6 min read
UNION therapeutics announces presentation of new data on orismilast at the EADV Congress 2023

UNION therapeutics A/S announced acceptance of a late-breaking oral presentation at the European Academy of Dermatology and Venerology Congress 2023 on October 11-14, 2023, in Berlin, Germany.

October 6, 2023
·
4 min read
Asceneuron Welcomes Barbara Angehrn Pavik as New CEO as It Gears Up for Next Phase of Growth

Asceneuron SA announced the appointment of Barbara Angehrn Pavik as the new Chief Executive Officer, as part of a leadership transition poised to propel the company into its next phase of growth, with two compounds in clinical development.

October 6, 2023
·
2 min read
US Patent Office Allows Patent Claims for Intellectual Property Exclusively Licensed to Renalytix

Renalytix plc announces that the US Patent Office has issued a new notice of allowance of claims surrounding the biomarkers sTNFR1 and sTNFR2 used in the kidneyintelX.dkd test.

October 6, 2023
·
6 min read
LSL Pharma Group Engages Paradox as Investor Relations Services Provider

LSL Pharma Group Inc. is pleased to announce that it has retained on October 5, 2023 the services of Paradox Public Relations Inc. to provide investor relations services on behalf of the Company.

October 6, 2023
·
1 min read
BioMidwest

Ocuphire Pharma to Present at Euretina and Retina Society Conferences in OctoberPresentations Will Feature Data From ZETA-1 Phase 2 Trial of APX3330 in Diabetic Retinopathy

Ocuphire Pharma, Inc. today announced presentations featuring results from the ZETA-1 Phase 2 Trial of APX3330 at the 23rd Euretina Congress.

October 6, 2023
·
4 min read
Deals

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)-October 6, 2023

Insmed Incorporated today announced the granting of inducement awards to 16 new employees.

October 6, 2023
·
2 min read
Business

XVIVO Perfusion AB Announces Conference call on Interim Report

XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO’s conference call regarding the presentation of the interim report July-September 2023.

October 6, 2023
·
1 min read